Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Shanghai Ninth People'S Hospital Shanghai Jiaotong University School Of Medicine has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are spread across 3 distinct examiners and several art units. Eric J Rosen is the busiest examiner for the portfolio, responsible for 1 pending office action. The equal number of pending actions and examiners indicates that each active matter is being reviewed by a different individual.
This distribution across 3 distinct art units suggests that the hospital's medical device research covers several different technical classifications within the patent office. For practitioners, this variety means that prosecution strategies must be tailored to the specific standards of multiple examination groups. The decentralized nature of the portfolio across different art units indicates a broad technical scope for the institution's current medical engineering developments.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROSEN, ERIC J | 1 | 41.3% | +22.8% |
| BURKHART, MICHAEL D | 1 | 62.3% | +11.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18029112 | Use of an intervertebral disc fibrosis-inducing substance in preparation of medication | BURKHART, MICHAEL D | 2d overdue |
| 18693535 | Dental Braces | ROSEN, ERIC J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18029112 | Use of an intervertebral disc fibrosis-inducing substance in preparation of medication | BURKHART, MICHAEL D | 2d overdue |
| 18693535 | Dental Braces | ROSEN, ERIC J | — |
| Art Unit | Apps |
|---|---|
| 3772 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18693535 | Dental Braces | ROSEN, ERIC J | 3772 | §101§103§112 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18029112 | Use of an intervertebral disc fibrosis-inducing substance in preparation of medication | BURKHART, MICHAEL D | 1638 | §101§102§112 | Non-Final OA | 2d overdue | Pending | Nov 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial